#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.MedicalEntity|DCT|MedicalEntity
#T_RL=webanno.custom.TLINK|TLINK|BT_webanno.custom.MedicalEntity


#Text=Journalnotat 1 - 12.07.2025
#Text=Neurologisk oppfølgingstime for MS-pasient.
1-1	0-12	Journalnotat	_	_	_	_	
1-2	13-14	1	_	_	_	_	
1-3	15-16	-	_	_	_	_	
1-4	17-27	12.07.2025	_	_	_	_	
1-5	28-39	Neurologisk	OVERLAP[1]	TREATMENT[1]	_	_	
1-6	40-55	oppfølgingstime	OVERLAP[1]	TREATMENT[1]	_	_	
1-7	56-59	for	_	_	_	_	
1-8	60-70	MS-pasient	_	_	_	_	
1-9	70-71	.	_	_	_	_	

#Text=Økende symptomer med balanseforstyrrelser og periodiske synsforstyrrelser.
2-1	72-78	Økende	OVERLAP[2]	CONDITION[2]	OVERLAP|OVERLAP	2-6[3_2]|2-4[0_2]	
2-2	79-88	symptomer	OVERLAP[2]	CONDITION[2]	_	_	
2-3	89-92	med	_	_	_	_	
2-4	93-113	balanseforstyrrelser	OVERLAP	CONDITION	OVERLAP|OVERLAP	2-6[3_0]|2-1[2_0]	
2-5	114-116	og	_	_	_	_	
2-6	117-127	periodiske	OVERLAP[3]	CONDITION[3]	OVERLAP	2-4[0_3]	
2-7	128-145	synsforstyrrelser	OVERLAP[3]	CONDITION[3]	_	_	
2-8	145-146	.	_	_	_	_	

#Text=MR-scanning viser nye inflammatoriske lesjoner i sentralnervesystemet.
3-1	147-158	MR-scanning	OVERLAP	TREATMENT	_	_	
3-2	159-164	viser	_	_	_	_	
3-3	165-168	nye	_	_	_	_	
3-4	169-184	inflammatoriske	OVERLAP[4]	CONDITION[4]	BEFORE	3-1[0_4]	
3-5	185-193	lesjoner	OVERLAP[4]	CONDITION[4]	_	_	
3-6	194-195	i	OVERLAP[4]	CONDITION[4]	_	_	
3-7	196-216	sentralnervesystemet	OVERLAP[4]	CONDITION[4]	_	_	
3-8	216-217	.	_	_	_	_	

#Text=Iverksetter justering av sykdomsmodifiserende behandling og vurderer rehabiliteringstiltak.
4-1	218-229	Iverksetter	_	_	_	_	
4-2	230-239	justering	AFTER[5]	TREATMENT[5]	OVERLAP	4-8[0_5]	
4-3	240-242	av	AFTER[5]	TREATMENT[5]	_	_	
4-4	243-263	sykdomsmodifiserende	AFTER[5]	TREATMENT[5]	_	_	
4-5	264-274	behandling	AFTER[5]	TREATMENT[5]	_	_	
4-6	275-277	og	_	_	_	_	
4-7	278-286	vurderer	_	_	_	_	
4-8	287-308	rehabiliteringstiltak	AFTER	TREATMENT	OVERLAP	4-2[5_0]	
4-9	308-309	.	_	_	_	_	
